The Uromigos
Striving to provide balanced, scientific content related to care of patients with GU malignancies. …
Related Articles
A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses
In a cohort of patients with a small renal mass (SRM) matched for age and health status, 5-yr outcomes for those managed with active surveillance…
2022 Meeting — The Uromigos
Uromigos Live 2023 will take place in Nashville November 3-4, 2023. More details coming soon! …
The Uromigos
Striving to provide balanced, scientific content related to care of patients with GU malignancies. …
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial
CheckMate -901 is the first and only Phase 3 trial with an immunotherapy-based combination to demonstrate a survival benefit compared to standard-of-care cisplatin-based combinations in…
The Uromigos
Striving to provide balanced, scientific content related to care of patients with GU malignancies. …
